Why FTLF Stock dropped -4.70% Today — RQD Quant Desk Flash

$7.91 -4.70% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $7.83

FitLife Brands Inc. (FTLF) carries a Roarable Rating of D (Sell) with 45/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $74.3M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on FTLF Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is FTLF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, FitLife Brands Inc. (NASDAQ: FTLF) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $7.91 (-4.70% 1D, market cap $74.3M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 7/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, FTLF ranks #417 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does FTLF compare to ISPR and BTMD in the Health Care sector?
▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), FTLF carries a Roarable D (45/100 RQD), trailing P/E of 11.7x, gross margin of 43.1%, and ROIC of 5.4%. By comparison, ISPR (Ispire Technology Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $79.1M) and BTMD (Biote Corp. (Class A)) posts a D grade (50/100 RQD, P/E N/A, ROIC 85.0%, cap $42.0M). Among the 5-stock peer group, NAGE leads on earnings multiple (11.4x) while BTMD leads on capital efficiency (85.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for FTLF?
▼

Per FTLF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001374328), FitLife Brands Inc. generated $15.9M in revenue (-75.3% YoY), $6.3M in net income, and $7.4M in free cash flow against $106.3M in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $7.83 (-1.04%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 46.4% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (45/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.3% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510045
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D-
Cash (9)Whales (3)SEC (7)Macro (10)CEO (16)
Each axis scored 0–20
12M PRICE TARGET CONE-5.8% Base Target
$21 Bull$7 Base$6 Bear
📬 FREE FTLF RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for FTLF)Realized 20D OHLCV Swing Band: ±10.2%
Deterministic 5-Pillar Attribution (45/100 Composite)
🔍 WHY FTLF SCORES 45/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (36% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)

▲ #2 Bullish Driver: Macro Regime Fit+10/20 pts (22% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 31.7 (OVERSOLD (<32))

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
53
Grade C-$9.23-10.8% Next Q
Q2 (-2Q)
50
Grade C-$8.23+1.1% Next Q
Q3 (-1Q)
48
Grade D$8.32-4.9% Next Q
Current
45
Grade D$7.91-6.3% Hist 90D α
Trajectory: C- (53) → D (45)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a FTLF Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While FTLF currently carries a cautious 45/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Company leadership has skin in the game with net positive insider conviction.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.11) and Max Pain ($8.31) forces dealer call-delta covering toward $20.95.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-2.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $FTLF• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “FTLF Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why FTLF Stock dropped -4.70% Today — RQD Quant Desk Flash

FitLife Brands Inc. (FTLF) dropped -4.70% to $7.91, trading at 2% of its 52-week range ($7.66 – $19.95). Stretched risk/reward at 12x P/E (5% return on capital) under elevated 10-year interest-rate pressure.

  • ▸Technical Tape: Trading at 2% of its 52-week range ($7.66 – $19.95) with RSI-14 at 31.7 (OVERSOLD (<32)).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±10.2% around $7.91 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable D (Sell) backed by 43.1% gross margin and $7.4M annual free cash flow.
Live FTLF Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring FTLF)

  • ✓Walkthrough of FTLF's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
FTLF // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -18.03%🛡️ HOLDING TREND SUPPORT
2026-11-02O $8.30H $8.30L $7.91C $7.91VOL 21.8K
RES: $9.42SUP: $7.59SMA50: $9.11SMA200: $11.13
$16.47$14.08$11.69$9.31$6.92RES $9.42SUP $7.59$7.912026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

FTLF Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
2.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on FTLF today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for FTLF. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for FTLF today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (FTLF)

Health Care Rank #417 of 1016 ⚔️ ISPR vs FTLF Full Matrix →

1. Head-to-Head Health Care Peer Comparison (FTLF vs. ISPR, BTMD, MDWD, NAGE)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, FitLife Brands Inc. (FTLF) ranks #417 by composite RQD confidence (45/100, grade D) and #697 by equity capitalization ($74.3M). Within this direct 5-issuer industry benchmark cohort, NAGE leads on earnings valuation at 11.4x trailing P/E, while BTMD leads on capital efficiency and profitability with 85.0% ROIC and — gross margin. NAGE currently holds the highest overall quantitative score in the immediate peer group at 57/100 (D+) compared with FTLF at 45/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
FTLF ACTIVE
FitLife Brands Inc.
D 45/100 11.7x 43.1% 5.4% -4.70% $74.3M Benchmark Subject
ISPR
Ispire Technology Inc.
E 24/100 — 17.8% -35.0% -1.44% $79.1M /ispr-vs-ftlf →
BTMD
Biote Corp. (Class A)
D 50/100 — — 85.0% +1.74% $42.0M /btmd-vs-ftlf →
MDWD
MediWound Ltd.
D 51/100 — — — +2.21% $178.9M /mdwd-vs-ftlf →
NAGE
Niagen Bioscience Inc.
D+ 57/100 11.4x 64.3% 16.8% -1.57% $197.8M /nage-vs-ftlf →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001374328

In its most recent audited fiscal period (FY2025, filed 2025-12-31), FitLife Brands Inc. (FTLF) reported GAAP revenue of $15.9M (-75.3% vs. FY2024 revenue of $64.5M ) , GAAP net income of $6.3M, operating cash flow of $7.4M, and free cash flow of $7.4M (-22.9% YoY). On the balance sheet, FTLF closed FY2025 with $106.3M in total assets against $0 in total debt (Altman Z-Score: 1.24, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $15.9M $6.3M $7.4M $7.4M $106.3M —
FY2024 (FY) 2024-12-31 $64.5M $9.0M $9.6M $9.6M $58.5M $8.6M
FY2023 (FY) 2023-12-31 $0 $5.3M $4.2M $4.2M — —

3. FTLF Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is FTLF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, FitLife Brands Inc. (NASDAQ: FTLF) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $7.91 (-4.70% 1D, market cap $74.3M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 7/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, FTLF ranks #417 in composite RQD confidence.

How does FTLF compare to ISPR and BTMD in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), FTLF carries a Roarable D (45/100 RQD), trailing P/E of 11.7x, gross margin of 43.1%, and ROIC of 5.4%. By comparison, ISPR (Ispire Technology Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $79.1M) and BTMD (Biote Corp. (Class A)) posts a D grade (50/100 RQD, P/E N/A, ROIC 85.0%, cap $42.0M). Among the 5-stock peer group, NAGE leads on earnings multiple (11.4x) while BTMD leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for FTLF?

Per FTLF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001374328), FitLife Brands Inc. generated $15.9M in revenue (-75.3% YoY), $6.3M in net income, and $7.4M in free cash flow against $106.3M in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is FTLF trading relative to its 50-day, 200-day, and 52-week technical levels?

FTLF last traded at $7.91 (-4.70% on volume of 21,788 shares), positioning the stock -13.17% below its 50-day simple moving average ($9.11) and -28.93% below its 200-day simple moving average ($11.13). Across its 52-week range of $7.66 to $19.95, FTLF sits at the 2.0% percentile with a 14-day RSI of 31.7 (OVERSOLD (<32)) and an implied next-earnings move of ±10.2% ($7.10 to $8.72).

FTLF Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Why is FTLF stock moving today?

Why FTLF Stock dropped -4.70% Today — RQD Quant Desk Flash. Stretched risk/reward at 12x P/E (5% return on capital) under elevated 10-year interest-rate pressure.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%